Patent · US Active

Inhibitors of NF-κB activity

US8691764B2 · kind B2 · utility

0Cited by

1References

56Claims

0Family size

Assignee

The Research Foundation for The State University of New York · US

Inventors

Zhiquan Zhang · Shandong, CN
Basil Rigas · White Plains, US

Key dates

Filing date	Mar 28, 2008
Grant date	Apr 8, 2014
Priority date	—
Expiry date	Jul 12, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides a method for inhibiting NF-κB activity in a subject, the method comprising providing an agent capable of inducing expression of annexin 1, whereby said agent induces expression of annexin 1 and whereby said induced expression of annexin 1 inhibits NF-κB activity. Also provided are annexin 1 mimetics capable of binding to NF-κB and pharmaceutical compositions of such inducing and mimetic agents.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.